REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmagal d.o.o. (Croatia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pharmagal d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharmagal d.o.o. is a company in Croatia, with a head office in Dugopolje. It operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on January 15, 2026. 10 (2024) employees currently work for Pharmagal d.o.o.. In 2024, the company reported a net sales revenue increase of 16.12%. During that time, Pharmagal d.o.o.’s total assets grew by 64.22%. The net profit margin of Pharmagal d.o.o. increased by 11.52% in 2024.

Headquarters
Dugopoljska 3 Str.
Dugopolje; Split - Dalmatia; Postal Code: 21204

Contact Details: Purchase the Pharmagal d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmagal d.o.o. report to view the information.
Financial Auditors:
Purchase the Pharmagal d.o.o. report to view the information.
Incorporation Date:
January 15, 2026
Key Executives
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmagal d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
16.12%
Total operating revenue
16.12%
Operating profit (EBIT)
115.91%
EBITDA
115.91%
Net Profit (Loss) for the Period
118.6%
Total Assets
64.22%
Total Equity
67.54%
Operating Profit Margin (ROS)
14.4%
Net Profit Margin
11.52%
Return on Equity (ROE)
9.41%
Debt/Equity
10.33%
Quick Ratio
0.15%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?